Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer - Test2 - elhamkhani - TriplyDB

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

http://www.wikidata.org/entity/Q34384632

about

Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?Autophagy-Regulating microRNAs and Cancer MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer.An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.Small nucleolar RNA U91 is a new internal control for accurate microRNAs quantification in pancreatic cancer.The Host Shapes the Gut Microbiota via Fecal MicroRNA Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma The Development of Our Organ of Other Kinds-The Gut Microbiota.Genomic medicine for cancer diagnosis.Current and future biomarkers for pancreatic adenocarcinoma.Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?Noncoding RNAs in Cancer Diagnosis.Early detection of pancreatic cancer: Where are we now and where are we going?Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression.Connective tissue growth factor (CCN2) and microRNA-21 are components of a positive feedback loop in pancreatic stellate cells (PSC) during chronic pancreatitis and are exported in PSC-derived exosomes.miR-216a-5p acts as an oncogene in renal cell carcinoma.The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes.MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives

P2860

Q26767120-5EF7D660-9550-48C5-9184-FEE0EAE15C1B Q26769953-39985E6E-0A0A-4BE0-870F-B56FE1B600F6 Q26799779-4E969DBF-A162-4608-9248-23D23484BC0B Q33572337-BBE56B1B-D3F6-4AFB-8199-D36AFE027840 Q34704824-027BD301-7916-45B1-982D-2A71C0E2F95A Q35811250-78CA22F9-DF6B-485B-BF23-2F793A07F78A Q35820915-1C2318E6-7466-4522-9364-942C855DFEF4 Q35893557-5E68B436-31F1-400E-8CB8-1AD2877B8ED8 Q36052700-A93BC348-3899-4D77-A510-E53DE236F72F Q36644146-626FA2B0-A3C1-4027-A2D6-4ADEABC5C678 Q37528480-71503E24-FD2E-4A39-8206-9AE249168CEF Q38262839-3D817990-6131-4AD9-8088-2C8C3445AAB4 Q38670577-00CC7A19-4D11-4B9A-96DE-E00ABB5885A9 Q38855547-A08AC235-9F11-4C17-BBC9-F627176ABD2F Q38885507-C1A656F7-6D67-4A18-8660-303F07D10A47 Q39152619-0AFF0786-C479-4373-B4F4-ABBBBC3EA34C Q39202824-134E524A-CF5A-4FFA-8A06-68BB66D03149 Q40904292-9E26F0B7-BDC3-4A3E-94F6-5CE46BE073A9 Q54094665-EDA6B9B1-5F8E-4E3E-8517-AED144FFEE9C Q55245154-661A64CD-DB24-434C-AA91-E7958CDC6784 Q57169572-8C8C39ED-A5D3-4F06-89E9-6E5941835E44

P2860

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

http://www.wikidata.org/entity/Q34384632

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

@ast

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

@en

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

@nl

type

label

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

@ast

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

@en

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

@nl

prefLabel

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

@ast

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

@en

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

@nl

P1433

Q34384632-9BC81276-E776-4543-AAE6-8977FD60D423

P1476

Q34384632-971ED33F-43C3-4FB6-A847-D200F0FEEB27

P2093

Q34384632-2B1D7989-AC77-45CB-9E30-7520CBC8646F

Q34384632-43E98F43-3838-4344-B463-A7EDFF493D42

Q34384632-A81E0BE8-C000-4308-8FA4-DE46A9D593CB

P2860

Q34384632-0783B5E8-051C-4C79-8DF8-2B81F940BA06

Q34384632-094A0450-C4CB-495A-8F2E-75879DE3382F

Q34384632-162DA778-DF77-40B7-8230-8D9232193797

Q34384632-16612D61-88D3-4791-BC4A-953115D11392

Q34384632-18F4040C-5C26-4FCC-990D-D6067929D4B6

Q34384632-1AF4DD58-FBA5-4CB0-9419-4F8B15381243

Q34384632-1C28DE35-C64D-435B-A985-2C02154D698F

Q34384632-247DCD73-C1DE-4818-A0A7-5CE43686D330

Q34384632-294C4FD9-7C8B-4DC3-A213-DE56150D3751

Q34384632-29FB0D92-8E7E-49AD-A875-E350B199EB65

P304

Q34384632-07AE16A6-00A6-4388-A3DB-DA24D357E3CA

P31

Q34384632-DCB8F000-7B28-4A96-80B2-12F78842B3D1

P356

Q34384632-EA96EF7D-6E4B-4F7C-BCA8-B19468CC9769

P407

Q34384632-531771AF-F9CB-4EC4-AD2D-AA42063B53F4

P433

Q34384632-61DF3132-3B10-4C49-AC97-8BE7BCE85819

P478

Q34384632-AB35305C-97C9-4CA0-B774-422C2ADF0AA2

P50

Q34384632-90E1DA37-4273-405C-BCE3-C0DEF95C261F

Q34384632-95987A25-F3D1-4DB9-B1DC-DB02CB1431B7

P577

Q34384632-0A7F024D-9E4C-4FEE-8A4A-794A63327798

P5875

Q34384632-32C5105D-FC33-4344-AAA0-F034CE2C0714

P698

Q34384632-80A8316A-5340-4575-81CC-2713B30E0CDD

P921

Q34384632-821AFA80-0D80-4862-91C7-AA016D2BDAED

Q34384632-950C0EE1-8666-44A2-AA07-3DF640AC6798

Q34384632-A17479A0-A9D5-4D24-95EA-7163D1253241

P932

Q34384632-9E90BDCC-7DE8-4549-9C30-1B6AC1825285

P356

JOURNAL.PONE.0042933

P1433

P1476

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer

@en

P2093

Peter Malfertheiner

http://www.w3.org/2001/XMLSchema#string

Thomas Wex

http://www.w3.org/2001/XMLSchema#string

Verena Becker

http://www.w3.org/2001/XMLSchema#string

P2860

A microRNA expression signature of human solid tumors defines cancer gene targets

MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1)

Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis

Circulating microRNAs as stable blood-based markers for cancer detection.

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

The functions of animal microRNAs

MicroRNA signatures in human cancers

MicroRNA expression profiles classify human cancers

Screening of high-risk families for pancreatic cancer

A pancreatic islet-specific microRNA regulates insulin secretion

P304

e42933

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0042933

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230699926

http://www.w3.org/2001/XMLSchema#string

P698

22905187

http://www.w3.org/2001/XMLSchema#string

P921

P932

3414456

http://www.w3.org/2001/XMLSchema#string